An innovative treatment for Pneumocystis pneumonia

肺孢子菌肺炎的创新治疗方法

基本信息

  • 批准号:
    8873445
  • 负责人:
  • 金额:
    $ 7.9万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-06-15 至 2017-05-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Pneumocystis jirovecii is a fungus that causes Pneumocystis pneumonia (PCP) in humans which remains a leading opportunistic infection associated with AIDS patients, even in the era of Highly Active Anti-Retroviral Therapy (HAART). PCP increasingly targets new groups of patients with underlying chronic disease states, such as patients receiving anti-TNF therapy, other immunosuppressive agents and with underlying chronic diseases such as Chronic Obstructive Pulmonary Disorder (COPD). The combination therapy of trimethoprim- sulfamethoxazole (TMP-SMX) remains the standard prophylactic and therapeutic modality in use today with few alternative treatments. Evidence for mutations associated with resistance to sulfamethoxazole has been identified in the P. jirovecii dihydropteroate synthase encoding gene. It is thus critical that new approaches to anti-PCP therapy be developed. In this proposal, we will build on our previous observations that slightly acidified nitrite (A-NO2-), a nitric oxide (NO) generator, was effective in preventing the formatio of in vitro biofilms by Pneumocystis carinii and decreased viability in standard suspension cultures. Ongoing toxicology studies in dogs and rats and Phase I human trials revealed A-NO2- was well tolerated at doses up to 19-20 mg/kg, respectively, with minimal side effects, which bodes well for translation of these efforts. We propose to evaluate 2 different delivery modes for A-NO2- in therapeutic and prophylaxis mouse models of PCP at 3 different doses to determine the most effective administration route and treatment times that reduce fungal lung burdens. Initial immunological studies will guide further mechanistic experiments to determine the mode of action of this new alternative agent.
 描述(由申请方提供):耶氏肺孢子虫是一种真菌,可引起人类肺孢子虫肺炎(PCP),即使在高效抗逆转录病毒治疗(HAART)时代,PCP仍是与艾滋病患者相关的主要机会性感染。PCP越来越多地针对具有潜在慢性疾病状态的新患者群体,例如接受抗TNF治疗的患者,其他免疫抑制剂和患有慢性阻塞性肺疾病(COPD)等潜在慢性疾病的患者。甲氧苄啶-磺胺甲恶唑(TMP-SMX)的联合治疗仍然是目前使用的标准预防和治疗方式,替代治疗很少。与磺胺甲恶唑抗性相关的突变的证据已在耶氏疟原虫二氢蝶酸合酶编码基因中鉴定。因此,开发抗PCP治疗的新方法至关重要。在这项建议中,我们将建立在我们以前的观察,轻微酸化的亚硝酸盐(A-NO2-),一氧化氮(NO)的产生者,是有效地防止卡氏肺孢子虫在体外生物膜的形成和标准悬浮培养的活力下降。正在进行的狗和大鼠毒理学研究以及I期人体试验显示,A-NO2-在剂量高达19-20 mg/kg时耐受性良好,副作用最小,这预示着这些努力的转化。我们建议在3种不同剂量的PCP治疗和预防小鼠模型中评估2种不同的A-NO2-给药模式,以确定减少真菌肺负荷的最有效给药途径和治疗时间。初步的免疫学研究将指导进一步的机制实验,以确定这种新的替代剂的作用模式。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DANIEL J. HASSETT其他文献

DANIEL J. HASSETT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DANIEL J. HASSETT', 18)}}的其他基金

Mechanism Underlying Nitrite Sensitivity of Mucoid Pseudomonas in COPD
COPD 中粘液假单胞菌亚硝酸盐敏感性的机制
  • 批准号:
    7931027
  • 财政年份:
    2010
  • 资助金额:
    $ 7.9万
  • 项目类别:
Mechanism Underlying Nitrite Sensitivity of Mucoid Pseudomonas in COPD
COPD 中粘液假单胞菌亚硝酸盐敏感性的机制
  • 批准号:
    8391607
  • 财政年份:
    2010
  • 资助金额:
    $ 7.9万
  • 项目类别:
Mechanism Underlying Nitrite Sensitivity of Mucoid Pseudomonas in COPD
COPD 中粘液假单胞菌亚硝酸盐敏感性的机制
  • 批准号:
    8196343
  • 财政年份:
    2010
  • 资助金额:
    $ 7.9万
  • 项目类别:
Role of OxyR in P. aeruginosa Biofilm Resistance to H202
OxyR 在铜绿假单胞菌生物膜 H2O2 抗性中的作用
  • 批准号:
    7271227
  • 财政年份:
    2004
  • 资助金额:
    $ 7.9万
  • 项目类别:
Role of OxyR in P. aeruginosa Biofilm Resistance to H202
OxyR 在铜绿假单胞菌生物膜 H2O2 抗性中的作用
  • 批准号:
    6831086
  • 财政年份:
    2004
  • 资助金额:
    $ 7.9万
  • 项目类别:
Role of OxyR in P. aeruginosa Biofilm Resistance to H202
OxyR 在铜绿假单胞菌生物膜 H2O2 抗性中的作用
  • 批准号:
    6931186
  • 财政年份:
    2004
  • 资助金额:
    $ 7.9万
  • 项目类别:
Role of OxyR in P. aeruginosa Biofilm Resistance to H202
OxyR 在铜绿假单胞菌生物膜 H2O2 抗性中的作用
  • 批准号:
    7111811
  • 财政年份:
    2004
  • 资助金额:
    $ 7.9万
  • 项目类别:
Proteogenome of Anaerobic P. aeruginosa in CF Mucus
CF 粘液中厌氧铜绿假单胞菌的蛋白质组
  • 批准号:
    6609992
  • 财政年份:
    2003
  • 资助金额:
    $ 7.9万
  • 项目类别:
B.pseudomallei bioterrorism and quorum sensing
B.pseudomallei 生物恐怖主义和群体感应
  • 批准号:
    6659914
  • 财政年份:
    2002
  • 资助金额:
    $ 7.9万
  • 项目类别:
B.pseudomallei bioterrorism and quorum sensing
B.pseudomallei 生物恐怖主义和群体感应
  • 批准号:
    6556955
  • 财政年份:
    2002
  • 资助金额:
    $ 7.9万
  • 项目类别:

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 7.9万
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    $ 7.9万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    $ 7.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 7.9万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    $ 7.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 7.9万
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    $ 7.9万
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    $ 7.9万
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    $ 7.9万
  • 项目类别:
Downsides of downhill: The adverse effects of head vibration associated with downhill mountain biking on visuomotor and cognitive function
速降的缺点:与速降山地自行车相关的头部振动对视觉运动和认知功能的不利影响
  • 批准号:
    2706416
  • 财政年份:
    2022
  • 资助金额:
    $ 7.9万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了